Edition:
India

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,461.35INR
12:45pm IST
Change (% chg)

Rs-8.40 (-0.34%)
Prev Close
Rs2,469.75
Open
Rs2,461.35
Day's High
Rs2,473.80
Day's Low
Rs2,460.00
Volume
2,186
Avg. Vol
10,881
52-wk High
Rs2,798.50
52-wk Low
Rs2,201.20

Chart for

About

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The... (more)

Overall

Beta: 0.19
Market Cap(Mil.): Rs209,644.20
Shares Outstanding(Mil.): 84.70
Dividend: 30.00
Yield (%): 1.21

Financials

  Industry Sector
P/E (TTM): -- 32.81 16.63
EPS (TTM): -- -- --
ROI: -- 14.96 33.78
ROE: -- 16.51 17.31

BRIEF-Glaxosmithkline Pharmaceuticals ‍appoints Puja Thakur as CFO​

* Says ‍appointed Puja Thakur as whole-time director and CFO​ Source text: http://bit.ly/2gDubM1 Further company coverage:

25 Oct 2017

BRIEF-India's Glaxosmithkline Pharmaceuticals Sept-qtr profit up 32 pct

* Sept quarter profit 1.30 billion rupees versus profit of 988.5 million rupees last year

25 Oct 2017

BRIEF-India's Glaxosmithkline Pharmaceuticals June-qtr profit down about 63 pct

* June quarter profit 264.2 million rupees versus profit of 722.7 million rupees last year

25 Jul 2017

Earnings vs. Estimates